HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Doris Marko Selected Research

delphinidin

3/2018Delphinidin protects colon carcinoma cells against the genotoxic effects of the mycotoxin altertoxin II.
1/2017Genistein and delphinidin antagonize the genotoxic effects of the mycotoxin alternariol in human colon carcinoma cells.
12/2013Delphinidin is a novel inhibitor of lymphangiogenesis but promotes mammary tumor growth and metastasis formation in syngeneic experimental rats.
9/2009Delphinidin inhibits a broad spectrum of receptor tyrosine kinases of the ErbB and VEGFR family.
10/2008Impact of delphinidin on the maintenance of DNA integrity in human colon carcinoma cells.
7/2008Comparison of delphinidin, quercetin and (-)-epigallocatechin-3-gallate as inhibitors of the EGFR and the ErbB2 receptor phosphorylation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Doris Marko Research Topics

Disease

30Carcinoma (Carcinomatosis)
06/2022 - 02/2002
25Neoplasms (Cancer)
12/2023 - 02/2002
10Colonic Neoplasms (Colon Cancer)
11/2023 - 04/2005
8Poisoning
03/2020 - 04/2009
5Carcinogenesis
04/2013 - 09/2006
4Body Weight (Weight, Body)
01/2020 - 03/2010
3Neoplasm Metastasis (Metastasis)
01/2023 - 09/2009
3Inflammation (Inflammations)
01/2020 - 11/2018
3Adenocarcinoma
12/2018 - 01/2017
2Urinary Bladder Neoplasms (Bladder Cancer)
12/2023 - 09/2016
2Endometrial Neoplasms (Endometrial Cancer)
10/2023 - 01/2018
2Breast Neoplasms (Breast Cancer)
01/2022 - 01/2020
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2021 - 01/2018
2Hepatocellular Carcinoma (Hepatoma)
03/2020 - 04/2012
1Herpes Zoster
01/2022
1Leukemia
11/2021
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021
1Multiple Myeloma
11/2021
1Starvation
04/2020
1Malnutrition (Nutritional Deficiencies)
01/2020
1Infections
01/2019
1Autistic Disorder (Autism)
10/2016

Drug/Important Bio-Agent (IBA)

17DNA (Deoxyribonucleic Acid)IBA
03/2020 - 10/2008
10Anthocyanins (Anthocyanin)IBA
11/2023 - 04/2009
10MycotoxinsIBA
01/2021 - 04/2012
7alternariolIBA
01/2022 - 04/2012
6deoxynivalenolIBA
01/2022 - 01/2016
6delphinidinIBA
03/2018 - 07/2008
5GenisteinIBA
01/2022 - 01/2016
5Type II DNA Topoisomerases (Topoisomerase II)IBA
11/2021 - 03/2009
5PolyphenolsIBA
01/2018 - 04/2005
5ErbB Receptors (EGF Receptor)IBA
05/2013 - 05/2007
4Proteins (Proteins, Gene)FDA Link
01/2022 - 03/2010
4altertoxin IIIBA
01/2020 - 03/2018
4Type I DNA Topoisomerases (Topoisomerase I)IBA
11/2016 - 04/2009
4PoisonsIBA
11/2016 - 03/2009
3Transcription Factors (Transcription Factor)IBA
01/2023 - 12/2018
3ZearalenoneIBA
01/2022 - 01/2016
3Phosphotransferases (Kinase)IBA
11/2021 - 09/2009
3EnzymesIBA
03/2020 - 03/2010
3IceIBA
03/2020 - 03/2010
3methylamphotericin B (AME)IBA
01/2020 - 04/2009
3Estrogens (Estrogen)FDA Link
01/2018 - 01/2017
3Doxorubicin (Adriamycin)FDA LinkGeneric
12/2014 - 03/2009
2Estrogen ReceptorsIBA
10/2023 - 01/2022
2LipidsIBA
01/2023 - 06/2022
23-hydroxycholest-7-ene-14-carbaldehydeIBA
01/2022 - 12/2018
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2020 - 04/2012
2MicroRNAs (MicroRNA)IBA
10/2019 - 11/2018
2Alkaline PhosphataseIBA
03/2017 - 01/2017
2Silicon Dioxide (Silica)FDA LinkGeneric
01/2017 - 05/2013
2Topoisomerase InhibitorsIBA
01/2017 - 10/2016
2Tenuazonic AcidIBA
01/2016 - 12/2012
2ResveratrolIBA
12/2015 - 12/2014
2GlycosidesIBA
04/2013 - 05/2008
2LigandsIBA
12/2012 - 04/2009
23-hydroxyflavoneIBA
12/2012 - 07/2008
2CoffeeFDA Link
10/2011 - 05/2011
2QuercetinIBA
07/2008 - 09/2006
1WortmanninIBA
12/2023
1XenobioticsIBA
12/2023
1Protein Isoforms (Isoforms)IBA
10/2023
1Fatty Acids (Saturated Fatty Acids)IBA
01/2023
1IsotopesIBA
01/2022
1OccludinIBA
01/2022
1Claudin-4IBA
01/2022
1CholesterolIBA
01/2022
1Caveolin 1IBA
01/2022
1IntegrinsIBA
01/2022
13,8-dihydroxy-6H-dibenzo(b,d)pyran-6-oneIBA
01/2022
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2021
1Tyrosine Kinase InhibitorsIBA
11/2021
1CrizotinibIBA
11/2021
1TubulinIBA
11/2021
1AntioxidantsIBA
01/2021
1ProteomeIBA
01/2021
1Messenger RNA (mRNA)IBA
04/2020
1Insulin (Novolin)FDA Link
04/2020
1CytokinesIBA
04/2020
1trioctyl phosphine oxide (TOPO)IBA
03/2020
1AflatoxinsIBA
03/2020
1Food Additives (Food Additive)IBA
03/2020
1altertoxin IIBA
01/2020
1alternariol monomethyl etherIBA
01/2020
1TrichothecenesIBA
01/2020
1Bacterial ToxinsIBA
01/2020
1cereulideIBA
01/2020
1Hormones (Hormone)IBA
01/2019
1LipopolysaccharidesIBA
11/2018
1xanthohumolIBA
01/2018
18-prenylnaringeninIBA
01/2018
13'-oxomethylisoeugenolIBA
11/2016
1methyleugenol-2',3'-epoxideIBA
11/2016
1methyleugenol (methyl eugenol)IBA
11/2016
1Sulfates (Sulfates, Inorganic)IBA
09/2016
1enniatinsIBA
01/2016
1aurofusarinIBA
01/2016

Therapy/Procedure

3Therapeutics
01/2017 - 12/2004
2Chemoprevention
04/2013 - 04/2009